Market Overview:
The global livestock anti-infective medicine market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of animal diseases, rising demand for meat and milk products, and growing awareness about animal health and hygiene. The global livestock anti-infective medicine market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into external use and internal use. External use dominates the global livestock anti-infective medicine market owing to its easy availability and low cost as compared to internal use products. On the basis of application, cattle accounts for a major share in terms of revenue in 2017 owing to their high population across regions worldwide followed by swine and poultry respectively.
Product Definition:
Livestock Anti Infective Medicine is a type of veterinary medicine used to prevent and treat infections in livestock animals. It is important for keeping livestock healthy and productive, and preventing the spread of infection to other animals or people.
External Use:
External Use is a new term in the Livestock Anti Infective Medicine (LAIM) market. It means that the drug or vaccine is used for non-medical purposes, such as farming and other similar activities. External Use generally includes vaccines against bovine spongiform encephalopathy (BSE), porcine epidemic diarrhea virus (PEDv), sheep scrapie, avian influenza A & H5N1 & H1N1 etc.
Internal Use:
Internal use anti-infective medicines are used to treat infections in the body cavity or internally. The most common types of infections treated with internal use anti-infectives are respiratory tract, urinary tract and wound infections. Internal Use Anti Infective (IUAI) is a category of drugs that includes antibiotics as well as antiviral agents used for treatment and prevention of diseases caused by bacteria, viruses or fungi.
Application Insights:
Based on the application, the global livestock anti-infective medicine market is segmented into cattle, equine, swine and poultry. The cattle segment held the largest share in 2017 due to extensive usage of antibiotics in dairy and beef production. According to a study published by Food and Agriculture Organization (FAO) of United Nations in 2016, it was estimated that around 60% of antibiotics produced worldwide are consumed by cows. This has resulted in emergence as a key driver for demand generation.
The swine segment is expected to witness lucrative growth over forecast period owing to rising prevalence of diseases such as porcine circovirus (PCV), African horse sickness (AHS) and trichinae parasite among others which are highly prevalent among pigs across the globe. In addition, increasing consumption of pork products including bacon along with other meats globally will further boost industry growth over forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing awareness among farmers and livestock owners about Livestock Anti-Infective Medicine (LAIM) and proper usage of these products, which leads to better health and productivity of animals. In addition, high adoption rate for new technology in this region also contributes towards growth.
Asia Pacific is anticipated to witness a lucrative CAGR over the forecast period owing to rapid urbanization along with growing population that requires more food production at lower costs, thereby driving investments for animal health products development especially LAIVM solutions across emerging economies such as China & India & Indonesia etc.
Growth Factors:
- Increasing demand for meat and livestock products from developing countries is expected to drive the growth of the Livestock Anti Infective Medicine market.
- Rising awareness about animal health and hygiene is another key factor that is expected to fuel the growth of this market in the coming years.
- The increasing prevalence of zoonotic diseases is also anticipated to boost the demand for Livestock Anti Infective Medicine products in the near future.
- Growing investments by leading players in research and development activities are likely to propel the growth of this market in forthcoming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Livestock Anti Infective Medicine Market Research Report
By Type
External Use, Internal Use
By Application
Cattle, Equine, Swine, Poultry
By Companies
Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Livestock Anti Infective Medicine Market Report Segments:
The global Livestock Anti Infective Medicine market is segmented on the basis of:
Types
External Use, Internal Use
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cattle, Equine, Swine, Poultry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- Zoetis
- Merck
- Elanco
- Bayer
- Virbac
- Ceva Sante Animale
- Vetoquinol
- Bimeda Animal Health
- Chanelle
Highlights of The Livestock Anti Infective Medicine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- External Use
- Internal Use
- By Application:
- Cattle
- Equine
- Swine
- Poultry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Livestock Anti Infective Medicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Livestock anti-infective medicine (LAIM) is a group of medications used to prevent or treat infections in livestock. LAIM can be divided into two categories: antibiotics and vaccines. Antibiotics are drugs that kill bacteria. Vaccines are substances that help the body build immunity to diseases by exposing people to small amounts of the virus or disease before it causes serious illness.
Some of the major players in the livestock anti infective medicine market are Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle.
The livestock anti infective medicine market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Livestock Anti Infective Medicine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Livestock Anti Infective Medicine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Livestock Anti Infective Medicine Market - Supply Chain
4.5. Global Livestock Anti Infective Medicine Market Forecast
4.5.1. Livestock Anti Infective Medicine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Livestock Anti Infective Medicine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Livestock Anti Infective Medicine Market Absolute $ Opportunity
5. Global Livestock Anti Infective Medicine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Livestock Anti Infective Medicine Market Size and Volume Forecast by Type
5.3.1. External Use
5.3.2. Internal Use
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Livestock Anti Infective Medicine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Livestock Anti Infective Medicine Market Size and Volume Forecast by Application
6.3.1. Cattle
6.3.2. Equine
6.3.3. Swine
6.3.4. Poultry
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Livestock Anti Infective Medicine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Livestock Anti Infective Medicine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Livestock Anti Infective Medicine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Livestock Anti Infective Medicine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Livestock Anti Infective Medicine Demand Share Forecast, 2019-2026
9. North America Livestock Anti Infective Medicine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Livestock Anti Infective Medicine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Livestock Anti Infective Medicine Market Size and Volume Forecast by Application
9.4.1. Cattle
9.4.2. Equine
9.4.3. Swine
9.4.4. Poultry
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Livestock Anti Infective Medicine Market Size and Volume Forecast by Type
9.7.1. External Use
9.7.2. Internal Use
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Livestock Anti Infective Medicine Demand Share Forecast, 2019-2026
10. Latin America Livestock Anti Infective Medicine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Livestock Anti Infective Medicine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Livestock Anti Infective Medicine Market Size and Volume Forecast by Application
10.4.1. Cattle
10.4.2. Equine
10.4.3. Swine
10.4.4. Poultry
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Livestock Anti Infective Medicine Market Size and Volume Forecast by Type
10.7.1. External Use
10.7.2. Internal Use
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Livestock Anti Infective Medicine Demand Share Forecast, 2019-2026
11. Europe Livestock Anti Infective Medicine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Livestock Anti Infective Medicine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Livestock Anti Infective Medicine Market Size and Volume Forecast by Application
11.4.1. Cattle
11.4.2. Equine
11.4.3. Swine
11.4.4. Poultry
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Livestock Anti Infective Medicine Market Size and Volume Forecast by Type
11.7.1. External Use
11.7.2. Internal Use
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Livestock Anti Infective Medicine Demand Share, 2019-2026
12. Asia Pacific Livestock Anti Infective Medicine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Livestock Anti Infective Medicine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Livestock Anti Infective Medicine Market Size and Volume Forecast by Application
12.4.1. Cattle
12.4.2. Equine
12.4.3. Swine
12.4.4. Poultry
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Livestock Anti Infective Medicine Market Size and Volume Forecast by Type
12.7.1. External Use
12.7.2. Internal Use
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Livestock Anti Infective Medicine Demand Share, 2019-2026
13. Middle East & Africa Livestock Anti Infective Medicine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Livestock Anti Infective Medicine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Livestock Anti Infective Medicine Market Size and Volume Forecast by Application
13.4.1. Cattle
13.4.2. Equine
13.4.3. Swine
13.4.4. Poultry
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Livestock Anti Infective Medicine Market Size and Volume Forecast by Type
13.7.1. External Use
13.7.2. Internal Use
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Livestock Anti Infective Medicine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Livestock Anti Infective Medicine Market: Market Share Analysis
14.2. Livestock Anti Infective Medicine Distributors and Customers
14.3. Livestock Anti Infective Medicine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boehringer Ingelheim
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zoetis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Elanco
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bayer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Virbac
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ceva Sante Animale
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Vetoquinol
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bimeda Animal Health
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Chanelle
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
